{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T22:43:06Z","timestamp":1787352186283,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016808","name":"Natural Science Foundation of Xiamen City","doi-asserted-by":"publisher","award":["3502Z20227143"],"award-info":[{"award-number":["3502Z20227143"]}],"id":[{"id":"10.13039\/100016808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jaip.2023.01.027","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T02:38:52Z","timestamp":1675219132000},"page":"1494-1502.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Differences in Hypersensitivity Reactions to Iodinated Contrast Media: Analysis of the US Food and Drug Administration Adverse Event Reporting System Database"],"prefix":"10.1016","volume":"11","author":[{"given":"Xiuxian","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.01.027_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.2019190485","article-title":"Hypersensitivity reactions to iodinated contrast media: a multicenter study of 196 081 patients","volume":"293","author":"Cha","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2023.01.027_bib2","first-page":"1325","article-title":"Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity","volume":"76","author":"Torres","year":"2021"},{"key":"10.1016\/j.jaip.2023.01.027_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/cmmi.1475","article-title":"Classification of acute and delayed contrast media-induced reactions: proposal of a three-step system","volume":"7","author":"Bohm","year":"2012","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.jaip.2023.01.027_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.01.027_bib5","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jaip.2019.02.035","article-title":"Differences in adverse reactions among iodinated contrast media: analysis of the KAERS database","volume":"7","author":"An","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.027_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2214\/AJR.07.3421","article-title":"Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions","volume":"191","author":"Wang","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jaip.2023.01.027_bib7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00330-009-1698-6","article-title":"Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media?","volume":"20","author":"Gomi","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jaip.2023.01.027_bib8","article-title":"Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2023.01.027_bib9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ced.13991","article-title":"Contrast media and cutaneous reactions. Part 2: delayed hypersensitivity reactions to iodinated contrast media","volume":"44","author":"Tasker","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2023.01.027_bib10","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1097\/BCR.0b013e318257d88e","article-title":"Recurrent toxic epidermal necrolysis secondary to iopromide contrast","volume":"34","author":"Brown","year":"2013","journal-title":"J\u00a0Burn Care Res"},{"key":"10.1016\/j.jaip.2023.01.027_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","article-title":"Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA Adverse Event Reporting System (FAERS)","volume":"9","author":"Yu","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.027_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/RLI.0000000000000644","article-title":"HLA-DRB1\u221715: 02 is associated with iodinated contrast media-related anaphylaxis","volume":"55","author":"Chung","year":"2020","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jaip.2023.01.027_bib14","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.jaip.2020.03.030","article-title":"Urticaria and angioedema across the ages","volume":"8","author":"Saini","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.027_bib15","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140491","article-title":"Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing, China","volume":"88","author":"Li","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jaip.2023.01.027_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/cea.12803","article-title":"Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography","volume":"47","author":"Kim","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.01.027_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/RLI.0000000000000568","article-title":"Acute adverse reactions to nonionic iodinated contrast media: a meta-analysis","volume":"54","author":"Suh","year":"2019","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jaip.2023.01.027_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/cancers12040826","article-title":"Cardiovascular toxicity of tyrosine kinase inhibitors used in chronic myeloid leukemia: an analysis of the FDA Adverse Event Reporting System Database (FAERS)","volume":"12","author":"Cirmi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaip.2023.01.027_bib19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cancers13081758","article-title":"Thromboembolic events with cyclin-dependent kinase 4\/6 inhibitors in the FDA Adverse Event Reporting System","volume":"13","author":"Raschi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaip.2023.01.027_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/clpt.2013.24","article-title":"Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system","volume":"93","author":"Harpaz","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.01.027_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40264-014-0146-y","article-title":"Performance of probabilistic method to detect duplicate individual case safety reports","volume":"37","author":"Tregunno","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2023.01.027_bib23","article-title":"Cardiotoxicity induced by immune checkpoint inhibitors: a pharmacovigilance study from 2014 to 2019 based on FAERS","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2023.01.027_bib24","first-page":"1660","article-title":"Cardiovascular safety profile of romosozumab: a pharmacovigilance analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)","volume":"10","author":"Vestergaard Kvist","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jaip.2023.01.027_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40264-014-0187-2","article-title":"Performance of the standardised MedDRA(R) queries for case retrieval in the French spontaneous reporting database","volume":"37","author":"Geniaux","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2023.01.027_bib26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1517\/14740338.2014.915938","article-title":"A\u00a0comparison of disproportionality analysis methods in national adverse drug reaction databases of China","volume":"13","author":"Hou","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaip.2023.01.027_bib27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","article-title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database","volume":"72","author":"Montastruc","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2023.01.027_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaip.2018.06.030","article-title":"Controversies in drug allergy: radiographic contrast media","volume":"7","author":"Sanchez-Borges","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.027_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1002530","article-title":"Is computed tomography safe?","volume":"363","author":"Smith-Bindman","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.01.027_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2018.04.014","article-title":"Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2023.01.027_bib31","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.bja.2021.09.034","article-title":"Combining skin testing and basophil activation testing is useful for evaluation of life-threatening radiocontrast media anaphylaxis","volume":"128","author":"Li","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2023.01.027_bib32","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.jaip.2022.03.030","article-title":"Validation of practical pathway in patients with anaphylaxis to low osmolar contrast media: a retrospective cohort study","volume":"10","author":"Ahn","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.027_bib33","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3390\/ijms21041535","article-title":"Sex and gender aspects for patient stratification in allergy prevention and treatment","volume":"21","author":"De Martinis","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2023.01.027_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cea.12327","article-title":"Genetic risk factors for the development of allergic disease identified by genome-wide association","volume":"45","author":"Portelli","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.01.027_bib35","first-page":"613","article-title":"Cardiovascular events in men with prostate cancer receiving hormone therapy: an analysis of the FDA Adverse Event Reporting System (FAERS)","volume":"206","author":"Zhang","year":"2021","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jaip.2023.01.027_bib36","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1111\/epi.13828","article-title":"Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network","volume":"58","author":"Duke","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaip.2023.01.027_bib37","article-title":"Contrast-induced sialadenitis of the sublingual glands","volume":"2020","author":"Park","year":"2020","journal-title":"Case Rep Otolaryngol"},{"key":"10.1016\/j.jaip.2023.01.027_bib38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jpeds.2020.11.043","article-title":"Transient angioedema of the small bowel because of intravenous nonionic iodinated contrast media","volume":"230","author":"Wakabayashi","year":"2021","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2023.01.027_bib39","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/pds.4260","article-title":"Antihypertensive drug associated angioedema: effect modification by race\/ethnicity","volume":"26","author":"Reichman","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2023.01.027_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.18176\/jiaci.0058","article-title":"Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media","volume":"26","author":"Rosado Ingelmo","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.027_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/ACI.0000000000000454","article-title":"NSAIDs hypersensitivity: questions not resolved","volume":"18","author":"Blanca-Lopez","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.01.027_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","article-title":"Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department","volume":"100","author":"Banerji","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.01.027_bib43","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.jaip.2021.02.060","article-title":"DRESS and AGEP reactions to iodinated contrast media: a French case series","volume":"9","author":"Soria","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.01.027_bib44","doi-asserted-by":"crossref","first-page":"E1097","DOI":"10.1503\/cmaj.200364","article-title":"Acute generalized exanthematous pustulosis caused by an intravenous radiocontrast medium","volume":"192","author":"Tan","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.jaip.2023.01.027_bib45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.2014.7859","article-title":"Genetic variants associated with phenytoin-related severe cutaneous adverse reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2023.01.027_bib46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/SHK.0000000000000899","article-title":"Epidemiology of anaphylactic shock and its related mortality in hospital patients in Taiwan: a nationwide population-based study","volume":"48","author":"Liu","year":"2017","journal-title":"Shock"},{"key":"10.1016\/j.jaip.2023.01.027_bib47","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/cea.12520","article-title":"Anaphylaxis and cardiovascular disease: therapeutic dilemmas","volume":"45","author":"Lieberman","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.01.027_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(20)30543-2","article-title":"Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"396","author":"Walli-Attaei","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.01.027_bib49","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1016\/j.jaip.2021.04.006","article-title":"Prevention of drug hypersensitivity reactions: prescreening and premedication","volume":"9","author":"Thong","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823001137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:37:24Z","timestamp":1761975444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2213219823001137"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.027","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in Hypersensitivity Reactions to Iodinated Contrast Media: Analysis of the US Food and Drug Administration Adverse Event Reporting System Database","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}